<DOC>
	<DOCNO>NCT01255579</DOCNO>
	<brief_summary>New formulation extrafine particle long act beta-2 agonists+inhaled corticosteroid ( LABA+ICS ) able reach peripheral region lung . Objectives.The aim study assess effect small airway obstruction long-term treatment two different LABA+ICS combination asthma . Patients methods.Ten subject moderate persistent asthma enrol . After 4-week washout treat randomized cross-over design 24 week formoterol 12 mcg beclometasone 200 mcg HFA ( MDI ) b.i.d . ( FB ) salmeterol 50 mcg fluticasone 250 mcg ( diskus ) b.i.d . ( SF ) . At baseline end period subject underwent Asthma Control Test ( ACT ) Pulmonary Function Testing . The N2 phase III slope closing volume ( CV ) single breath washout test , DElta ( Heliox-air ) MEF50 % measure assess change peripheral airway function .</brief_summary>
	<brief_title>Effects Small Airways Two Long-term Extrafine Treatments Asthma</brief_title>
	<detailed_description>Study design After 4-week washout period , patient allow take salbutamol ( need ) , assign accord double-blind , double-dummy randomize crossover study one two follow 24-week treatment : 1 ) formoterol 12 µg plus beclomethasone HFA 200 µg ( MDI ) b.i.d. , 2 ) salmeterol 50 µg plus fluticasone propionate 250 µg ( diskus ) b.i.d.. Daily dose 400 µg beclomethasone HFA 500 µg fluticasone propionate equivalent , accord Global Initiative Asthma ( GINA ) International guidelines6 . At end first period another 4-week washout period , receive second randomized 24-week treatment . Adherence treatment base self-reports patient , declaration willingness continue participate study counter drug dos dispose inhaler . All patient train correctly inhale drug different device . At end washout period two treatment subject underwent Asthma Control Test ( ACT ) , oxygen saturation ( SaO2 ) measurement Pulmonary Function Testing ( PFT ) . The subject enrol obtainment write consent . The protocol approve local Ethic Committee . Asthma Control Test Subjects complete ACT questionnaire end washout treatment period . Asthma control assess validated Italian version ACT . They subjectively evaluate degree impairment cause asthma precede 4 week answer five question use five-point-scale . The ACT reliable validated tool , responsive change asthma control time . A cut-off score 19 less identifies subject poorly control asthma . Pulmonary Function Testing A computerized water-sealed light-bell Stead-Wells spirometer ( Biomedin , Padua , Italy ) use measure slow vital capacity ( SVC ) , inspiratory capacity ( IC ) , maximal flow-volume curve . The operator assist test software able verify electronically acceptability reproducibility spirometric maneuver . All spirometric test employ study fulfil recommendation American Thoracic Society . Total lung capacity ( TLC ) , functional residual capacity ( FRC ) residual volume ( RV ) obtain use plethysmographic method . The body plethysmograph variable flow , constant pressure-type frequency response flat 30 Hz ( Biomedin , Padua , Italy ) . Determination slope N2 phase III closing volume ( CV ) obtain single-breath nitrogen washout test ( SBWN2 ) ( Medical Graphics , St. Paul , MN , US ) . Subjects sit position exhale residual volume ( RV ) inhale slowly pure oxygen single breath TLC expire slowly TLC RV . The expired nitrogen concentration measure plotted function expire lung volume . This relationship fit linearly phase III slope N2 phase III compute automatically software . The onset phase IV identify trace software visual examination , require . The average value N2 phase III slope CV obtain two acceptable reproducible measurement ( expiratory slow vital capacity within 10 % ) select analysis . Expiratory maximal flow-volume curve breathe either air heliox ( oxygen 21 % helium 79 % ) also perform . Breathing mixture introduce bell spirometer 3-way stopcock connect ambient air cylinder contain humidify heliox ambient temperature pressure . In occasion , 3 slow deep breath total lung capacity , force expiratory maneuver perform start TLC without end-inspiratory pause . Measurements MEF50 % air heliox determination difference [ Delta ( Heliox-air ) MEF50 % ] obtain baseline subsequently correspond isovolume . Statistical analysis All value express mean ± SD . We use mean functional value two baseline comparison . Analysis variance variable interest among baseline two therapeutic regimen ( end treatment period ) perform Friedman 's test . Comparisons group make accord Wilcoxon test , allow . A p value &lt; 0.05 consider significant . Statistical analysis perform GraphPad Prism Version 4 ( GraphPad Software ; San Diego , CA , USA ) .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Beclomethasone</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<criteria>Moderate persistent bronchial asthma accord GINA guideline Associated respiratory disease Smoking history Oral corticosteroid previous six month Pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2008</verification_date>
	<keyword>asthma</keyword>
	<keyword>small airway</keyword>
	<keyword>inhaled corticosteroid</keyword>
</DOC>